NEW YORK, March 24, 2025 /PRNewswire/ -- Cohen & Steers, Inc. (NYSE: CNS) announced today that the Cohen & Steers Real Estate Securities Fund (CSZIX) has received a 2025 LSEG Lipper Fund Award for its strong risk-adjusted performance over the 10-year period, ended November 30, 2024. This is the tenth consecutive year Lipper has recognized the Fund. For 2025, the Real Estate category for the 10-year period included 136 share classes. Jason Yablon, Head of Listed Real Estate, said:"We are honored to be recogn ...

Core Insights - Xenon Pharmaceuticals Inc. is a neuroscience-focused biopharmaceutical company dedicated to developing therapeutics for patients with high unmet medical needs [3] Group 1: Company Presentation - Xenon Pharmaceuticals will present at the Stifel 2025 Virtual CNS Forum on March 18-19, 2025 [1] - The presentation will feature Dr. Chris Kenney, Chief Medical Officer, on March 19, 2025, from 12:00-12:25 PM Eastern Time [2] - A live audio webcast of the presentation will be available on the company's website and will be posted for replay after the event [2] Group 2: Product Development - The company is advancing an ion channel product portfolio targeting conditions such as epilepsy and depression [3] - Azetukalner is highlighted as a novel, highly potent, selective Kv7 potassium channel opener, currently in late-stage clinical development for multiple indications [3]

Core Insights - Neurocrine Biosciences, Inc. will participate in the Stifel 2025 Virtual CNS Forum on March 18, 2025, at 1:30 p.m. Eastern Time, with presentations from CEO Kyle Gano and CMO Eiry Roberts [1] - The live webcast of the event will be available on the company's website, with a replay accessible approximately one hour after the event and archived for about one month [2] Company Overview - Neurocrine Biosciences is a leading biopharmaceutical company focused on neuroscience, dedicated to developing treatments for neurological, neuroendocrine, and neuropsychiatric disorders [3] - The company has a diverse portfolio that includes FDA-approved treatments for conditions such as tardive dyskinesia, Huntington's disease-related chorea, classic congenital adrenal hyperplasia, endometriosis, and uterine fibroids, along with a robust pipeline of compounds in mid- to late-phase clinical development [3] - With three decades of experience, Neurocrine applies insights into neuroscience to address complex conditions and aims to relieve suffering for patients with significant unmet needs [3]

Core Viewpoint - Cohen & Steers, Inc. announces the retirement of Daniel P. Charles, Executive Vice President and Head of Global Distribution, after 37 years in sales leadership roles, with a search for his successor already underway [1][2]. Company Overview - Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, commodities, and multi-strategy solutions [3]. - The firm was founded in 1986 and is headquartered in New York City, with additional offices in London, Dublin, Hong Kong, Tokyo, and Singapore [3]. Leadership Transition - Daniel P. Charles has been instrumental in realigning U.S. distribution efforts to better meet client needs for real assets and alternative investment solutions, as well as expanding distribution across EMEA and APAC [2]. - Joseph Harvey, CEO, acknowledged Mr. Charles' contributions in enhancing distribution capabilities and building global sales teams, emphasizing a relationship culture and expanded marketing efforts [3].

Core Insights - Cohen & Steers, Inc. reported preliminary assets under management (AUM) of $88.6 billion as of February 28, 2025, reflecting an increase of $2.1 billion from $86.4 billion at January 31, 2025 [1][2]. Assets Under Management Summary - The increase in AUM was primarily driven by market appreciation of $2.3 billion, which was partially offset by distributions of $151 million and net outflows of $16 million [1][2]. - Breakdown of AUM by investment vehicle as of February 28, 2025: - Institutional Accounts: Total AUM increased to $34.18 billion, with net outflows of $264 million and market appreciation of $922 million [2]. - Open-end Funds: AUM rose to $42.886 billion, with net inflows of $247 million and market appreciation of $1.173 billion [2]. - Closed-end Funds: AUM increased to $11.492 billion, with minimal net inflows and market appreciation of $218 million [2].

Core Viewpoint - Cohen & Steers, Inc. has launched the Cohen & Steers SICAV Short Duration Preferred Income Fund, marking its second fund focused on the preferred securities market for UCITS investors, following the launch of the Cohen & Steers SICAV Preferred Income Fund in 2017 [1][4]. Company Overview - Cohen & Steers is a leading global investment manager specializing in real assets and alternative income, managing $18.3 billion in preferred securities since 2003 [4][7]. - The firm is headquartered in New York City and has offices in multiple global locations including London, Dublin, Hong Kong, Tokyo, and Singapore [7]. Fund Details - The new fund aims to provide high current income and capital preservation, focusing on investment-grade, institutional preferreds with a target duration of less than three years [3]. - The fund is managed by Elaine Zaharis-Nikas, along with Portfolio Managers Jerry Dorost and Robert Kastoff [3]. Market Insights - The preferred securities market is valued at $1.2 trillion, with significant opportunities driven by attractive market fundamentals and an increase in new issuances from institutional and non-financial companies [2][3]. - Preferred securities offer high yields, stable income, portfolio diversification, and low correlation to the broader fixed income market [2].

Investment Vehicles and Strategies - Cohen & Steers, Inc. manages three types of investment vehicles: open-end funds, institutional accounts, and closed-end funds[14]. - The company’s core investment strategies include U.S. Real Estate Securities, Global/International Real Estate Securities, and Private Real Estate, among others[27][28][29]. - In 2024, Cohen & Steers Income Opportunities REIT, Inc. commenced principal operations, focusing on high-quality, income-focused properties in the U.S.[17]. - In 2025, the company launched its first active exchange-traded funds (ETFs) with three strategies: U.S. real estate securities, preferred securities, and natural resource equities[18]. - The investment advisory fee rates vary based on the vehicle, investment strategy, and prevailing market conditions, impacting overall revenue generation[24]. Revenue and Financial Performance - Revenue from the wealth channel is derived from investment advisory, administration, distribution, and service fees, while institutional channel revenue comes from fees for managing advised and subadvised accounts[24]. - Revenue fluctuates with changes in total assets under management, influenced by market appreciation, contributions, withdrawals, and distributions[25]. - Revenue fluctuates with changes in the total value of assets under management, influenced by market appreciation and depreciation, contributions, withdrawals, and distributions[25]. Competition and Market Position - The company faces competition from global investment managers, commercial banks, and broker-dealers, with performance and fees being key competitive factors[36][38]. - Cohen & Steers competes with global and U.S. investment managers, commercial banks, and broker-dealers, with performance, price, and brand being principal sources of competition[36][38]. - The company may face increased competition from larger managers with greater brand recognition and resources, potentially impacting market share[39]. Regulatory Environment - Cohen & Steers is subject to regulation under U.S. federal and state laws, as well as applicable laws in other jurisdictions where it operates[40]. - The company has subsidiaries in various regions, including the U.S., UK, Hong Kong, and Japan, each subject to local regulatory requirements[41][42][43][45]. - CSCM, a subsidiary, is registered with the SEC and has exemptions allowing it to provide investment management services in Australia and Canada[41]. - CSUK, another subsidiary, is regulated by the UK Financial Conduct Authority and is subject to liquidity and capital resource requirements[42]. - CSAL, the Hong Kong-based subsidiary, is required to be licensed with the SFC for conducting regulated activities[43]. - CSS, a New York-based subsidiary, is subject to the SEC's Uniform Net Capital Rule, which may limit capital withdrawals and dividends[47]. Human Capital and Diversity - As of December 31, 2024, Cohen & Steers had 411 full-time employees globally, with 36% being women and 33% of U.S. employees being people of color[55]. - In 2024, 48% of firmwide new hires were women, and 40% of U.S. new hires were people of color[55]. - The company aligns its human capital strategies across four verticals: Talent Management & Organizational Strategy, People Analytics & Insights, Total Rewards, and HR Engagement[49]. - The company utilizes People Analytics & Insights to align HR initiatives with broader firm objectives and optimize talent management practices[51]. - The company has been recognized for five consecutive years as a "Best Place to Work in Money Management" by Pensions & Investments, highlighting its strong culture[54].

Core Viewpoint - Cohen & Steers, Inc. has declared a cash dividend of $0.62 per share for Q1 2025, marking a 5.1% increase from the previous quarter's dividend of $0.59 per share [1]. Company Overview - Cohen & Steers is a prominent global investment manager that specializes in real assets and alternative income, including listed and private real estate, preferred securities, infrastructure, resource equities, and commodities [2]. - The company was founded in 1986 and is headquartered in New York City, with additional offices located in London, Dublin, Hong Kong, Tokyo, and Singapore [2].

Group 1 - The Value Lab focuses on long-only value investment ideas, aiming for a portfolio yield of about 4% and has performed well over the last 5 years by engaging in international markets [1][2] - Cohen & Steers (NYSE: CNS) experienced declines in assets under management (AUM) towards the end of the year due to depreciation of the assets in which AUM was invested [2] - The Valkyrie Trading Society consists of analysts sharing high conviction and obscure developed market ideas that are expected to generate non-correlated and outsized returns in the current economic environment [3] Group 2 - The Value Lab offers members real-time updates, 24/7 chat support, regular global market news reports, feedback on stock ideas, new trades monthly, quarterly earnings write-ups, and daily macro opinions [2]

Core Insights - LG CNS has joined SAP's Regional Strategic Services Partner (RSSP) initiative to enhance its capabilities and reach in the APAC region [1][3] - The RSSP initiative aims to support partners in delivering industry-aligned solutions and joint go-to-market strategies [1][3] - LG CNS is the first Korean company and the fourth partner in the APAC region to join this initiative, aiming to expand its cloud ERP business [4] Company Developments - LG CNS plans to leverage its expertise in AI, cloud, and big data to drive next-generation ERP and SAP S/4HANA migration [5] - The company offers proprietary solutions like 'PerfecTwin ERP Edition' for error detection during SAP S/4HANA migration and 'SINGLEX,' a SaaS platform for integrated management functions [6][8] - The partnership with SAP is expected to enhance client value and drive business innovation in the Asia-Pacific region [7][8] Strategic Goals - LG CNS aims to scale its SAP practice quickly across the APAC region and collaborate closely with SAP for joint customer success [3][4] - The initiative requires partners to meet specific criteria, including geographical presence and vertical industry competencies [7]